These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 25599018)

  • 1. Human Cardiac Tissue Engineering: From Pluripotent Stem Cells to Heart Repair.
    Jackman CP; Shadrin IY; Carlson AL; Bursac N
    Curr Opin Chem Eng; 2015 Feb; 7():57-64. PubMed ID: 25599018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
    Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
    Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional engineered human cardiac patches prepared from nature's platform improve heart function after acute myocardial infarction.
    Wang Q; Yang H; Bai A; Jiang W; Li X; Wang X; Mao Y; Lu C; Qian R; Guo F; Ding T; Chen H; Chen S; Zhang J; Liu C; Sun N
    Biomaterials; 2016 Oct; 105():52-65. PubMed ID: 27509303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering human ventricular heart muscles based on a highly efficient system for purification of human pluripotent stem cell-derived ventricular cardiomyocytes.
    Li B; Yang H; Wang X; Zhan Y; Sheng W; Cai H; Xin H; Liang Q; Zhou P; Lu C; Qian R; Chen S; Yang P; Zhang J; Shou W; Huang G; Liang P; Sun N
    Stem Cell Res Ther; 2017 Sep; 8(1):202. PubMed ID: 28962583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac applications for human pluripotent stem cells.
    Shiba Y; Hauch KD; Laflamme MA
    Curr Pharm Des; 2009; 15(24):2791-806. PubMed ID: 19689350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Potential of Pluripotent Stem Cells for Cardiac Repair after Myocardial Infarction.
    Okano S; Shiba Y
    Biol Pharm Bull; 2019; 42(4):524-530. PubMed ID: 30930411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concise review: reprogramming strategies for cardiovascular regenerative medicine: from induced pluripotent stem cells to direct reprogramming.
    Budniatzky I; Gepstein L
    Stem Cells Transl Med; 2014 Apr; 3(4):448-57. PubMed ID: 24591731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues.
    Feric NT; Radisic M
    Adv Drug Deliv Rev; 2016 Jan; 96():110-34. PubMed ID: 25956564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-engineered cardiac patch seeded with human induced pluripotent stem cell derived cardiomyocytes promoted the regeneration of host cardiomyocytes in a rat model.
    Sugiura T; Hibino N; Breuer CK; Shinoka T
    J Cardiothorac Surg; 2016 Dec; 11(1):163. PubMed ID: 27906085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue Engineering Techniques for Induced Pluripotent Stem Cell Derived Three-Dimensional Cardiac Constructs.
    Salem T; Frankman Z; Churko JM
    Tissue Eng Part B Rev; 2022 Aug; 28(4):891-911. PubMed ID: 34476988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naturally Engineered Maturation of Cardiomyocytes.
    Scuderi GJ; Butcher J
    Front Cell Dev Biol; 2017; 5():50. PubMed ID: 28529939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair.
    Hartman ME; Dai DF; Laflamme MA
    Adv Drug Deliv Rev; 2016 Jan; 96():3-17. PubMed ID: 25980938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroconductive biomaterials for cardiac tissue engineering.
    Esmaeili H; Patino-Guerrero A; Hasany M; Ansari MO; Memic A; Dolatshahi-Pirouz A; Nikkhah M
    Acta Biomater; 2022 Feb; 139():118-140. PubMed ID: 34455109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constraining the Pluripotent Fate of Human Embryonic Stem Cells for Tissue Engineering and Cell Therapy - The Turning Point of Cell-Based Regenerative Medicine.
    Parsons XH
    Br Biotechnol J; 2013 Oct; 3(4):424-457. PubMed ID: 24926434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in Bioengineering Strategies for Heart Regenerative Medicine.
    Häneke T; Sahara M
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frame-Hydrogel Methodology for Engineering Highly Functional Cardiac Tissue Constructs.
    Helfer A; Bursac N
    Methods Mol Biol; 2021; 2158():171-186. PubMed ID: 32857373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marching towards regenerative cardiac therapy with human pluripotent stem cells.
    Maher KO; Xu C
    Discov Med; 2013 Jun; 15(85):349-56. PubMed ID: 23819949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embryonic stem cell transplantation: promise and progress in the treatment of heart disease.
    Zhang F; Pasumarthi KB
    BioDrugs; 2008; 22(6):361-74. PubMed ID: 18998754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrospun Scaffolds and Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Cardiac Tissue Engineering Applications.
    Suh TC; Amanah AY; Gluck JM
    Bioengineering (Basel); 2020 Sep; 7(3):. PubMed ID: 32899986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to repair a broken heart with pluripotent stem cell-derived cardiomyocytes.
    Eschenhagen T; Ridders K; Weinberger F
    J Mol Cell Cardiol; 2022 Feb; 163():106-117. PubMed ID: 34687723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.